2-(3-(Bromomethyl)-2-fluorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 5g

3-Amino-4-iodopyridine, 95.0%, 25g

5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-4-(trifluoromethyl)pyrimidin-2-amine, 95.0%, 100mg

Filtres pour seringues Minisart® NML stériles (stérilisés à l'ETO), 1,2 µm, 50 pièce(s)

(S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-4,4-difluoro-butyric acid, 98.0%, 5g

4-Methyl-(5-hydroxymethyl)imidazole hydrochloride, 95.0%, 5g

2-Chloro-6-methoxypyridin-4-amine, 95.0%, 250mg

N-methyl-1-(1,3,5-trimethyl-1H-pyrazol-4-yl)ethanamine oxalate, 95.0%, 1g

1-(4-Bromophenyl)-2,2,2-trifluoroethanol, 95.0%, 5g

Diethoxypillar[6]arene>95.0%(HPLC)(qNMR)1g

2,2,2-Trifluoro-1-phenyl-ethylamine, 94.0%, 5g

Methyl 2,4-difluorobenzoate, 98.0%, 10g

4-(Aminomethyl)-1-N-Boc-piperidine, 97.0%, 1g